UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

A Clarithromycin-Induced Myasthenic Syndrome

Clinical infectious diseases, 1996-01, Vol.22 (1), p.175-176

1996

Volltextzugriff (PDF)

Oral Tegafur folinic acid chemotherapy decreases phenytoin efficacy

British journal of cancer, 2004-02, Vol.90 (3), p.745-745

2004

Volltextzugriff (PDF)

Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease

Annals of oncology, 1997-12, Vol.8 (12), p.1235-1241

1997

Volltextzugriff (PDF)

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group

European journal of cancer (1990), 2004-09, Vol.40 (14), p.2077-2081

2004

Volltextzugriff (PDF)

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

European journal of cancer (1990), 2003-03, Vol.39 (4), p.481-487

2003

Volltextzugriff (PDF)

Drug therapy for gynaecological cancer in older women

Drugs & aging, 2000-07, Vol.17 (1), p.13-32

2000

Volltextzugriff (PDF)

Suramin: rapid loading and weekly maintenance regimens for cancer patients

Journal of clinical oncology, 1992-11, Vol.10 (11), p.1788-1794

1992

Volltextzugriff (PDF)

Major complications and causes of death in patients treated for Hodgkin's disease

Journal of clinical oncology, 1987-10, Vol.5 (10), p.1624-1633

1987

Volltextzugriff (PDF)

Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin

Clinical pharmacology and therapeutics, 2001-08, Vol.70 (2), p.132-141

2001

Volltextzugriff (PDF)

The effect of schedule, protein binding and growth factors on the activity of suramin

International journal of cancer, 1992-07, Vol.51 (6), p.921-926

1992

Volltextzugriff (PDF)

Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease

Journal of clinical oncology, 1989-12, Vol.7 (12), p.1776-1782

1989

Volltextzugriff (PDF)

Suramin awakes ?

Journal of clinical oncology, 1992-06, Vol.10 (6), p.875-877

1992

Volltextzugriff (PDF)

The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-α treatment

Cancer letters, 1993-01, Vol.68 (1), p.25-31

1993

Volltextzugriff (PDF)

A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapy

Oncology, 1993-07, Vol.50 (4), p.316

1993

Volltextzugriff (PDF)

A case of brain metastases from male breast cancer responding to tamoxifen

European journal of cancer (1990), 1997-11, Vol.33 (13), p.2282-2283

1997

Volltextzugriff (PDF)

Five‐year survival in Hodgkin's disease. The prospective value of immune status at diagnosis

Cancer, 1986-04, Vol.57 (8), p.1489-1496

1986

Volltextzugriff (PDF)

Effect of suramin on adenylate cyclase and protein kinase C

Anti-cancer drug design, 1994-08, Vol.9 (4), p.279

1994

Volltextzugriff (PDF)

The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin

European journal of cancer (1990), 1994, Vol.30A (10), p.1545-1549

1994

Volltextzugriff (PDF)

High-dose intensity regimens with epirubicin in ovarian cancer

Seminars in oncology, 1994-02, Vol.21 (1 Suppl 1), p.17

1994

Volltextzugriff (PDF)

Workshop on suramin with emphasis on prostate cancer: Re-evaluation of response criteria

European journal of cancer (1990), 1993, Vol.29 (3), p.298-300

1993

Volltextzugriff (PDF)

The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract

International journal of gynecological cancer, 1994-01, Vol.4 (1), p.52-60

1994

Volltextzugriff (PDF)

High-dose intensity regimens with epirubicin in ovarian cancer: A role of dose-intensified chemotherapy with supportive care

Seminars in oncology, 1994, Vol.21 (1), p.17-22

1994

Volltextzugriff (PDF)

New prospects for immune status assessment in Hodgkin's disease

Netherlands journal of medicine, 1986, Vol.29 (12), p.415

Van Rijswijk, R E

1986

Volltextzugriff (PDF)

A prospective study of the changes in the immune status before, during, and after multiple‐agent chemotherapy for Hodgkin's disease

Cancer, 1983-02, Vol.51 (4), p.637-644

1983

Volltextzugriff (PDF)

Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients

Surgery, 1982-07, Vol.92 (1), p.21-29

1982

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(79)
Humans
(68)
Female
(42)
Middle Aged
(36)
Male
(33)
Biological And Medical Sciences
(30)
Adult
(27)
Aged
(27)
Medical Sciences
(27)
Oncology
(23)
Pharmacology. Drug Treatments
(16)
Cardiovascular System & Cardiology
(15)
Medicine
(12)
Medicine & Public Health
(12)
Prospective Studies
(12)
Antineoplastic Agents
(11)
Chemotherapy
(11)
Radiology, Nuclear Medicine & Medical Imaging
(11)
Treatment Outcome
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Clarithromycin-Induced Myasthenic Syndrome

Oral Tegafur folinic acid chemotherapy decreases phenytoin efficacy

Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

Drug therapy for gynaecological cancer in older women

Suramin: rapid loading and weekly maintenance regimens for cancer patients

Major complications and causes of death in patients treated for Hodgkin's disease

Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin

The effect of schedule, protein binding and growth factors on the activity of suramin

Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease

Suramin awakes ?

The cellular composition in the peritoneal cavity and the cytotoxic function of the peritoneal cells from patients with ovarian cancer; effect of tumor necrosis factor-α treatment

A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapy

A case of brain metastases from male breast cancer responding to tamoxifen

Five‐year survival in Hodgkin's disease. The prospective value of immune status at diagnosis

Effect of suramin on adenylate cyclase and protein kinase C

The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin

High-dose intensity regimens with epirubicin in ovarian cancer

Workshop on suramin with emphasis on prostate cancer: Re-evaluation of response criteria

The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract

High-dose intensity regimens with epirubicin in ovarian cancer: A role of dose-intensified chemotherapy with supportive care

New prospects for immune status assessment in Hodgkin's disease

A prospective study of the changes in the immune status before, during, and after multiple‐agent chemotherapy for Hodgkin's disease

Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients

Suchergebnisse filtern